摘要
Previously,living donor liver transplantation was considered as a“high-risk,high-return”medical treatment due to the relatively high short-term mortality.It is our task to change“high-risk,high-return”into a“low-risk,high-return”situation.In this review article,the recent evolutions in living donor liver transplantation for both donors and recipients at Kyoto University such as portal vein pressure modulation,hybrid donor operation,and perioperative management considering sarcopenia,focusing on improvement of short-term outcomes are described.Under a paradigm of“marketing and innovation”,various innovations and efforts have been made over the last decade aiming at improving the short-term outcomes of both donors and recipients.By doing so,excellent short-term results after living donor liver transplantation have been achieved,along with a potentially epoch-making discoveries.
